Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. 4 Open-market buy Ex VP, Internal Operations bought 10,000 shares at $4.66 ($46,600)
  2. 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $5.02 ($25,075)
  3. 4 Open-market buy Chief Business Officer bought 30,000 shares at $5.16 ($154,800)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4/A Exercise or conversion Director acquired 10,000 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 5,000 shares at $11.00 ($54,985)
  18. 4 Open-market buy Director bought 5,000 shares at $10.82 ($54,100)
  19. 4 Open-market sale Chief Business Officer sold 4,849 shares at $12.01 ($58,236)
  20. 4 Open-market sale Ex VP, Intern'l Operations sold 3,052 shares at $12.01 ($36,655)

Page 6 of 10 · 184 filings